Farmako ApS: Financial statements 2024
CVR: 40143548
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Farmako ApS (CVR 40143548) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -15,750 and a net result of DKK -15,749 compared with DKK -16,875 the year before. Equity in the 2024 report amounted to DKK -65,153.
- Gross Profit
- DKK -15,750
- Profit/Loss
- DKK -15,749
- Equity
- DKK -65,153
- Total Assets
- DKK 6,847
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -16 t. | -16 t. | -65 t. | - |
| 2023 | - | -17 t. | -17 t. | -49 t. | - |
| 2022 | - | -14 t. | -14 t. | -33 t. | - |
| 2021 | - | -13 t. | -13 t. | -19 t. | - |
| 2020 | - | -27 t. | -27 t. | -6 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Farmako ApS has published its annual report for 2023. Gross profit came to DKK -16,875, and the net result was DKK -16,875.
About Farmako ApS
Farmako ApS was a Danish company of the type Anpartsselskab based in København V, founded in 2019. The company has been dissolved on 19 June 2026. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. In 2024, the company reported a gross profit of DKK -15,750 and a net result of DKK -15,749 compared with DKK -16,875 the year before. Equity in the 2024 report amounted to DKK -65,153.